Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risks and complications of tocolysis

W C Hill1

  • 1Sarasota Memorial Hospital, Florida 34239-3555, USA.

Clinical Obstetrics and Gynecology
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Tocolytic therapy, used to delay preterm birth, carries significant maternal, fetal, and neonatal risks. Despite potential benefits, serious complications and even death can occur, necessitating cautious use and further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Jumping the broom toward eliminating health disparities. Presidential address.

American journal of obstetrics and gynecology·1999
Same author

Placenta previa, placenta abruptio.

Clinical obstetrics and gynecology·1998
Same author

Proteus pyomyositis of the piriformis muscle in a swimmer.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1998
Same author

Perinatal bacteremia due to group F streptococci.

American journal of perinatology·1992
Same author

Home uterine activity monitoring.

Clinics in perinatology·1992
Same author

Home monitoring of uterine activity.

The New England journal of medicine·1992

Area of Science:

  • Obstetrics and Gynecology
  • Pharmacology

Background:

  • Tocolytic therapy is frequently used to manage preterm labor.
  • Current tocolytic agents vary in efficacy and carry known risks.

Purpose of the Study:

  • To review maternal, fetal, and neonatal risks and complications associated with tocolytic therapy.
  • To highlight the need for clinician awareness regarding the adverse effects of tocolysis.

Main Methods:

  • Literature review of available information on tocolytic therapy risks and complications.

Main Results:

  • No ideal tocolytic agent currently exists.
  • Serious complications, including maternal, fetal, and neonatal death, can arise from tocolytic use.
  • The reduction of perinatal morbidity and mortality by tocolytic agents remains debatable.

Related Experiment Videos

Conclusions:

  • Clinicians must be aware of the significant side effects of all tocolytic agents, including oral terbutaline.
  • Caution is advised during both the initiation and continuation of tocolysis.
  • Further research is crucial to develop safer and more effective tocolytic drugs with improved administration methods.